Page last updated: 2024-08-23

ilmofosine and Cancer of Lung

ilmofosine has been researched along with Cancer of Lung in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dadey, ML; Gams, RA; McPhillips, JJ; Rodriguez, GI; Rowe, KW; Schultz, CJ; Von Hoff, DD; Woolley, PV	1
Berges, W; Ebeling, K; Hottenrott, G; Mechl, Z; Schlimok, G; Scholten, T; Sterz, R; Strohmeyer, G; Westerhausen, M; Winkelmann, M	1
Herrmann, DB; Munder, PG; Opitz, HG	1
Bicker, U; Herrmann, DB; Opitz, HG; Pahlke, W	1
Bicker, U; Herrmann, DB; Pahlke, W	1

Trials

2 trial(s) available for ilmofosine and Cancer of Lung

Article	Year
A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma. Investigational new drugs, 1996, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phospholipid Ethers	1996
Treatment results of the thioether lipid ilmofosine in patients with malignant tumours. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:6 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drug Evaluation; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Pancreatic Neoplasms; Phospholipid Ethers	1992

Article

Year

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.

Investigational new drugs, 1996, Volume: 14, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Phospholipid Ethers

1996

Treatment results of the thioether lipid ilmofosine in patients with malignant tumours.

Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:6

Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Drug Evaluation; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Pancreatic Neoplasms; Phospholipid Ethers

1992

Other Studies

3 other study(ies) available for ilmofosine and Cancer of Lung

Article	Year
Antitumor activity of Ilmofosine (BM 41.440) in the 3Lewis-lung carcinoma model. Lipids, 1991, Volume: 26, Issue:12 Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Phospholipid Ethers	1991
In vivo antitumor activity of ilmofosine. Cancer treatment reviews, 1990, Volume: 17, Issue:2-3 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Transplantation; Phospholipid Ethers	1990
BM 41.440: a new antineoplastic, antimetastatic, and immune-stimulating drug. Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc, 1987, Volume: 1 Topics: Alkaline Phosphatase; Animals; Cell Line; DNA Replication; Fibrosarcoma; Hemolysis; Humans; Leukemia L1210; Lung Neoplasms; Macrophages; Mice; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers; Tumor Cells, Cultured	1987